134 related articles for article (PubMed ID: 24532146)
1. The DJ-1 protein as a candidate biomarker in obstructive sleep apnea syndrome.
Vavougios G; Pastaka C; Tsilioni I; Natsios G; Seitanidis G; Florou E; Gourgoulianis KI
Sleep Breath; 2014 Dec; 18(4):897-900. PubMed ID: 24532146
[TBL] [Abstract][Full Text] [Related]
2. [Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Li J; Zhang Y; Wang J; Feng P; Chen R; Cao Y; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):403-7. PubMed ID: 24754980
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in patients with obstructive sleep apnea syndrome.
Ntalapascha M; Makris D; Kyparos A; Tsilioni I; Kostikas K; Gourgoulianis K; Kouretas D; Zakynthinos E
Sleep Breath; 2013 May; 17(2):549-55. PubMed ID: 22610662
[TBL] [Abstract][Full Text] [Related]
4. Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms.
Franco CM; Lima AM; Ataíde L; Lins OG; Castro CM; Bezerra AA; de Oliveira MF; Oliveira JR
J Mol Neurosci; 2012 Jun; 47(2):300-10. PubMed ID: 22402994
[TBL] [Abstract][Full Text] [Related]
5. Serum YKL-40 level is correlated with apnea hypopnea index in patients with obstructive sleep apnea sindrome.
Mutlu LC; Tülübaş F; Alp R; Kaplan G; Yildiz ZD; Gürel A
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4161-4166. PubMed ID: 29028081
[TBL] [Abstract][Full Text] [Related]
6. Can we use serum copeptin levels as a biomarker in obstructive sleep apnea syndrome?
Selcuk OT; Eyigor M; Renda L; Osma U; Eyigor H; Selcuk NT; Yılmaz MD; Demirkıran C; Unlu H; Gültekin M
J Craniomaxillofac Surg; 2015 Jul; 43(6):879-82. PubMed ID: 25957103
[TBL] [Abstract][Full Text] [Related]
7. The levels of advanced oxidation protein products in patients with obstructive sleep apnea syndrome.
Yağmur AR; Çetin MA; Karakurt SE; Turhan T; Dere HH
Ir J Med Sci; 2020 Nov; 189(4):1403-1409. PubMed ID: 32279237
[TBL] [Abstract][Full Text] [Related]
8. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
[TBL] [Abstract][Full Text] [Related]
9. Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome.
Sozer V; Kutnu M; Atahan E; Calıskaner Ozturk B; Hysi E; Cabuk C; Musellim B; Simsek G; Uzun H
Clin Respir J; 2018 Apr; 12(4):1615-1622. PubMed ID: 28960823
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid and lactate levels among patients with obstructive sleep apnea syndrome: which is a better marker of hypoxemia?
Hira HS; Shukla A; Kaur A; Kapoor S
Ann Saudi Med; 2012; 32(1):37-42. PubMed ID: 22156638
[TBL] [Abstract][Full Text] [Related]
11. Serum S100A12 and S100B proteins are independent predictors of the presence and severity of obstructive sleep apnea.
Demirci Sağlam G; Zamani A; Yosunkaya Ş; Kılınç İ
Turk J Med Sci; 2019 Jun; 49(3):746-754. PubMed ID: 31035738
[TBL] [Abstract][Full Text] [Related]
12. [Association between serum adipocyte fatty acid binding protein level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Wang YB; Chen R; Zhang YL; Li J; Shen JC; Xiong KP; Liu CF
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):94-7. PubMed ID: 22490689
[TBL] [Abstract][Full Text] [Related]
13. Relationship between inflammatory factors and arrhythmia and heart rate variability in OSAS patients.
Xie JY; Liu WX; Ji L; Chen Z; Gao JM; Chen W; Chen GF; Zhu Q
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2037-2053. PubMed ID: 32141573
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Serum Adropin, Adiponectin, and Proinflammatory Cytokine Levels in OSAS.
Celikhisar H; Ilkhan GD
Can Respir J; 2020; 2020():2571283. PubMed ID: 32454912
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].
Dumitrache-Rujinski S; Dinu I; Călcăianu G; Erhan I; Cocieru A; Zaharia D; Toma CL; Bogdan MA
Pneumologia; 2014; 63(2):100-2, 104-6. PubMed ID: 25241557
[TBL] [Abstract][Full Text] [Related]
16. Gamma-glutamyl transferase activity as a predictive marker for severity of obstructive sleep apnea syndrome and concomitant hypertension.
Bozkus F; Dikmen N; Demir LS
Clin Respir J; 2018 May; 12(5):1964-1973. PubMed ID: 29330970
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of body composition, adiponectin, C-reactive protein and cholesterol levels in patients with obstructive sleep apnea syndrome.
Kosacka M; Korzeniewska A; Jankowska R
Adv Clin Exp Med; 2013; 22(6):817-24. PubMed ID: 24431310
[TBL] [Abstract][Full Text] [Related]
18. Observational Study of Obstructive Sleep Apnea in Wake-Up Stroke: The SLEEP TIGHT Study.
Koo BB; Bravata DM; Tobias LA; Mackey JS; Miech EJ; Matthias MS; Stahl SM; Sico JJ; Vaz Fragoso CA; Williams LS; Lampert R; Qin L; Yaggi HK
Cerebrovasc Dis; 2016; 41(5-6):233-41. PubMed ID: 26811929
[TBL] [Abstract][Full Text] [Related]
19. Plasma level of hypoxanthine/xanthine as markers of oxidative stress with different stages of obstructive sleep apnea syndrome.
Hira HS; Samal P; Kaur A; Kapoor S
Ann Saudi Med; 2014; 34(4):308-13. PubMed ID: 25811203
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome.
Koseoglu HI; Altunkas F; Demir O; Doruk S; Etikan I; Benli I
Ann Saudi Med; 2013; 33(6):584-90. PubMed ID: 24413863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
